Weis Markets announced it has expanded its Weis Online Shopping service to eight New Jersey and Pennsylvania locations, bringing the convenience of online grocery orders with store pick-up to the Delaware Valley.
Eisai, the U.S. pharmaceutical arm of Tokyo-based Eisai Co., announced the launch of a new website, "Closing the Gap: Obesity Management for Employers," to provide employers with an educational resource for information about obesity management.
In its first year, more than 20,000 schools across all 50 states participated in the program that offers four free EpiPen or EpiPen Jr (epinephrine) Auto-Injectors to qualifying schools in the United States.
The new private-label dressing is based on the Medihoney HCS dressing, which is an ideal dressing for dry to lightly exuding wounds including minor burns, cuts and abrasions. The dressing is expected to be on the shelves in more than 4,000 stores by the end of September.
Stewart appeared at NACDS TSE to support the partnership between Martha Stewart Living Omnimedia and Inergetics, as well as to promote the launch of Martha Stewart Essentials — a complete line of whole-food-based supplements specifically targeted for women.
Pinnacle Foods announced that it has entered into a definitive agreement to acquire the Wish-Bone salad dressings business from Unilever PLC, in a transaction that is expected to be immediately accretive to Pinnacle. The acquisition, which is subject to customary closing conditions, is expected to be completed in late Q3 or early Q4 2013.
Reckitt Benckiser named Alexander Lacik, 48, to the position of president, Reckitt Benckiser North America, effective June 2013. Lacik reports directly to Rob de Groot, EVP Europe and North America, and will be a part of the ENA leadership team.
The Natural Dentist, a line of therapeutic oral care products, and Dr. Susan Calderbank, a leading dentist in oral health for patients undergoing chemotherapy and head and neck radiation, announced a partnership to raise awareness about the oral complications of cancer treatments in a joint effort to help patients manage these often debilitating side effects.